PREDICTIVE VALUE OF CA125, HE4 AND ROMA INDEX IN ENDOMETRIAL CANCER. PRELIMINARY RESULTS.

被引：0
|
作者：
Blontzos, N. [1 ]
Iavazzo, C. [1 ]
Galati, E. [1 ]
Vyllioti, V. [2 ]
Lamprou, E. [3 ]
Maliaros, A. [4 ]
Kalinoglou, N. [1 ]
Vorgias, G. [1 ]
机构：
[1] Metaxa Mem Canc Hosp, Gynecol Oncol, Piraeus, Greece
[2] Metaxa Mem Canc Hosp, Biochem Lab, Piraeus, Greece
[3] Metaxa Mem Canc Hosp, Biopathol Lab, Piraeus, Greece
[4] Metaxa Mem Canc Hosp, Biostat, Piraeus, Greece
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1293
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [21] Measurement of HE4 and CA125 and establishment of reference intervals for the ROMA index in the sera of pregnant women
    Lu, Jie
    Zheng, Zhipeng
    Zhang, Qi
    Li, Guoli
    Li, Fengying
    Le, Zhian
    Huang, Jun
    Xie, Xinyou
    Zhang, Jun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
  • [22] Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
    Njoku, Kelechi
    Barr, Chloe E.
    Sutton, Caroline J. J.
    Crosbie, Emma J.
    CANCERS, 2022, 14 (14)
  • [23] CA125 and HE4: Measurement Tools for Ovarian Cancer
    Zhao, Tingting
    Hu, Weiping
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2016, 81 (05) : 430 - 435
  • [24] The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay
    Yang, Jingjing
    Sa, Mu
    Huang, Meng
    Yang, Jiajin
    Xiang, Zhongyuan
    Liu, Bo
    Tang, Aiguo
    CLINICAL BIOCHEMISTRY, 2013, 46 (16-17) : 1705 - 1708
  • [25] Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
    Cymbaluk-Ploska, Aneta
    Gargulinska, Paula
    Bulsa, Michal
    Kwiatkowski, Sebastian
    Chudecka-Glaz, Anita
    Michalczyk, Kaja
    DIAGNOSTICS, 2021, 11 (04)
  • [26] PREOPERATIVE IDENTIFICATION OF HIGH RISK ENDOMETRIAL CANCER USING GRADE, HE4, AND CA125
    Kalogera, E.
    Cliby, W.
    Weaver, A.
    Podratz, K.
    Dowdy, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [27] HE4 and CA125 in ovarian malignancy
    Perovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S62 - S62
  • [28] Diagnostic performance of CA125, HE4, ROMA, and CPH-I in identifying primary ovarian cancer
    Luo, Hui-Jing
    Hu, Zhi-Dong
    Cui, Ming
    Zhang, Xiao-Fang
    Tian, Wen-Yan
    Ma, Chao-Qun
    Ren, Ya-Nv
    Dong, Zuo-Liang
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (03) : 998 - 1006
  • [29] Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis
    Wang, Jiwen
    Gao, Jia
    Yao, Hongwen
    Wu, Zongyong
    Wang, Minjie
    Qi, Jun
    TUMOR BIOLOGY, 2014, 35 (06) : 6127 - 6138
  • [30] HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer
    Ortiz-Munoz, Blanca
    Aznar-Oroval, Eduardo
    Garcia Garcia, Ana
    Covisa Peris, Amparo
    Perez Ballestero, Pilar
    Sanchez Yepes, Marina
    Garcia Lozano, Tomas
    Illueca Ballester, Carmen
    Garcia Garcia, Enrique
    TUMOR BIOLOGY, 2014, 35 (07) : 7249 - 7258
12345